Prevalence of symptoms of Raynaud's phenomenon in general practice
about
Calcium channel blockers for primary Raynaud's phenomenonDrug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocolCalcium channel blockers for primary Raynaud's phenomenonOral vasodilators for primary Raynaud's phenomenonHuman response to vibration stress in Japanese workers: lessons from our 35-year studies A narrative reviewAcupuncture in subjects with cold hands sensation: study protocol for a randomized controlled trial.Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.Adding Doppler ultrasonography to the follow-up of patients with vasospastic disorder improves objectivityHow can follow-up of patients with Raynaud phenomenon be optimized?Oral health of Chinese people with systemic sclerosis.Prevalence of Raynaud's phenomenon in a healthy Greek populationSymptoms of hand-arm vibration syndrome in gas distribution operatives.Raynaud's phenomenon of occupational origin.Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.The pathogenesis, diagnosis and treatment of Raynaud phenomenon.Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients.Management of Raynaud's phenomenon and digital ischemia.Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension.Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.Paraneoplastic Raynaud's phenomenon manifesting before the diagnosis of lung cancer.Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon.Raynaud's syndrome, an enigma after 130 years.Different factors influencing the expression of Raynaud's phenomenon in men and women.Raynaud's phenomenon and vitamin D.Calcium channel blockers for primary and secondary Raynaud's phenomenon.Association of Raynaud's phenomenon with a polymorphism in the NOS1 gene.
P2860
Q24186106-67E91CC3-298F-4DC4-ACA9-6CB815C46FB3Q24188181-42D7445B-2BAC-4C15-9180-67141C2C3A98Q24200938-C11177E6-7FAF-4883-B62F-6F8D4DF6FF41Q24202210-C9CC30BA-E09B-490C-AB09-A49F4240552CQ30395999-26383000-D3BD-450D-934E-1B5604204FB2Q34204907-E6F83A43-4DC7-4DDF-8808-93E870E51C7DQ34371560-7CEF4535-E07C-453B-A620-DF977A6E1E2BQ35073316-8F960482-6D77-46FD-8B80-FFA45EF2D179Q35388923-AA71826C-15DF-4CEC-936F-83A599D45ACDQ35539950-B997309F-52B9-4192-A795-629925B59B1AQ35549186-4035B748-2D52-4312-B3C2-11FEB96B7380Q35560528-4696B5AF-06F2-4A53-ABD8-E891048EFEBEQ36930058-64F081FF-283E-4D01-A37F-031985D51C5DQ37030669-1B4DBF53-1CF4-40C6-AC17-8114EB8F86EEQ38025285-C4568AD1-A098-4CC1-B9EE-CADC533009AEQ38028393-46F9386E-ED52-4F71-A5B2-4C9280434E6CQ38071979-0344FDCC-453B-468E-9C52-D061CC223B65Q38126803-8AF40C87-236A-45E1-88C2-6B0E837B2169Q38809851-AFF1E770-417D-4E50-8A5B-4F227D81E4E6Q39245536-099BCA40-A7D5-4739-A6E5-11EC545A80BFQ39395564-F41C5D99-33F2-47EB-82C3-D1546B9F8909Q39906701-72523FB9-494E-4D08-AD77-950D37DA53ACQ40316337-1DC019AF-E0E5-4A4E-8CF1-43F2EB4E01AEQ40880698-A3B1AD25-7403-42BE-B257-9C2C79664D86Q43852088-AE9CFB3F-C957-4F98-91BF-F69B14BE54C3Q45342518-F295A3B2-0D57-4073-872E-B20F95C95285Q47316559-33014590-37CF-4018-AB52-E71CC7444548Q54974849-DA44B3B2-CF5E-41C6-8849-6824A4812477
P2860
Prevalence of symptoms of Raynaud's phenomenon in general practice
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Prevalence of symptoms of Raynaud's phenomenon in general practice
@ast
Prevalence of symptoms of Raynaud's phenomenon in general practice
@en
type
label
Prevalence of symptoms of Raynaud's phenomenon in general practice
@ast
Prevalence of symptoms of Raynaud's phenomenon in general practice
@en
prefLabel
Prevalence of symptoms of Raynaud's phenomenon in general practice
@ast
Prevalence of symptoms of Raynaud's phenomenon in general practice
@en
P2093
P2860
P356
P1433
P1476
Prevalence of symptoms of Raynaud's phenomenon in general practice
@en
P2093
P2860
P304
P356
10.1136/BMJ.301.6752.590
P407
P577
1990-09-01T00:00:00Z